This observation raises a possibility that clinically the duration of certain chemotherapies may sometimes be shortened, i.e. be terminated before the tumor has regressed completely, especially when the patient experiences a fever fomented by the tumor per se or by treatment with a pyrogen such as interleukin-2 (IL-2). The gene discussed is IL2; the disease is neoplasm.